PubMed

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control.

Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M.

Filaria J. 2004 Aug 6;3(1):7.PMID: 15298709 [PubMed - as supplied by publisher]Related articlesFree article

Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.

Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.

Filaria J. 2005 Apr 7;4(1):2.PMID: 15817124 [PubMed - as supplied by publisher]Related articlesFree article

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, Boussinesq M.

Lancet. 1997 Jul 5;350(9070):18-22.PMID: 9217715 [PubMed - indexed for MEDLINE]Related articles

Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?

Pion SD, Clarke P, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

Parasitology. 2006 Jun;132(Pt 6):843-54. Epub 2006 Feb 10.PMID: 16469200 [PubMed - indexed for MEDLINE]Related articles

Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.

Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

Parasitology. 2006 Jul;133(Pt 1):101-9.PMID: 16764737 [PubMed - indexed for MEDLINE]Related articles

Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.

Pion DS, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux JP, Boussinesq M.

Parasitology. 2004 Nov;129(Pt 5):613-26.PMID: 15552406 [PubMed - indexed for MEDLINE]Related articles

Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.

Boussinesq M, Gardon J, Kamgno J, Pion SD, Gardon-Wendel N, Chippaux JP.

Ann Trop Med Parasitol. 2001 Jul;95(5):495-507.PMID: 11487371 [PubMed - indexed for MEDLINE]Related articles

Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.

Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH.

Lancet. 2000 Sep 23;356(9235):1077-8. Erratum in: Lancet 2000 Sep 30;356(9236):1198. PMID: 11009145 [PubMed - indexed for MEDLINE]Related articles

Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.

Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.

Filaria J. 2003 Oct 24;2 Suppl 1:S2.PMID: 14975059 [PubMed - as supplied by publisher]Related articlesFree article

Loiasis: the individual factors associated with the presence of microfilaraemia.

Pion SD, Demanou M, Oudin B, Boussinesq M.

Ann Trop Med Parasitol. 2005 Jul;99(5):491-500.PMID: 16004708 [PubMed - indexed for MEDLINE]Related articles

Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.

Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW.

Parasit Vectors. 2009 Aug 27;2(1):39.PMID: 19712455 [PubMed - in process]Related articlesFree article

[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin]

Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J, Schneider D, Chippaux JP.

Bull Soc Pathol Exot. 1995;88(3):105-12. French. PMID: 8555762 [PubMed - indexed for MEDLINE]Related articles

Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.

Esum M, Wanji S, Tendongfor N, Enyong P.

Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):673-6.PMID: 11816443 [PubMed - indexed for MEDLINE]Related articles

Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.

Boussinesq M, Gardon J.

Ann Trop Med Parasitol. 1997 Sep;91(6):573-89. Review.PMID: 9425360 [PubMed - indexed for MEDLINE]Related articles

Spatial modelling and the prediction of Loa loa risk: decision making under uncertainty.

Diggle PJ, Thomson MC, Christensen OF, Rowlingson B, Obsomer V, Gardon J, Wanji S, Takougang I, Enyong P, Kamgno J, Remme JH, Boussinesq M, Molyneux DH.

Ann Trop Med Parasitol. 2007 Sep;101(6):499-509.PMID: 17716433 [PubMed - indexed for MEDLINE]Related articles

Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).

Noma M, Nwoke BE, Nutall I, Tambala PA, Enyong P, Namsenmo A, Remme J, Amazigo UV, Kale OO, Sékétéli A.

Ann Trop Med Parasitol. 2002 Mar;96 Suppl 1:S29-39.PMID: 12081248 [PubMed - indexed for MEDLINE]Related articles

Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia.

Tsague-Dongmo L, Kamgno J, Pion SD, Moyou-Somo R, Boussinesq M.

Ann Trop Med Parasitol. 2002 Oct;96(7):707-15.PMID: 12537632 [PubMed - indexed for MEDLINE]Related articles

Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.

Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF, Okello D, Ozoh G, Remme J.

Ann Trop Med Parasitol. 2002 Apr;96(3):283-96.PMID: 12061975 [PubMed - indexed for MEDLINE]Related articles

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.

Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP.

Filaria J. 2003 Oct 24;2 Suppl 1:S4.PMID: 14975061 [PubMed - as supplied by publisher]Related articlesFree article

Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.

Twum-Danso NA, Meredith SE.

Trop Med Int Health. 2003 Sep;8(9):820-31.PMID: 12950668 [PubMed - indexed for MEDLINE]Related articlesFree article